BAXTER

Description

Pharmaceutical products, namely, injection solutions for human use in the fields of cardiovascular and critical care medicine; preparations for human health care in the fields of cardiovascular and critical care medicine; cardiovascular pharmaceutical preparations; local anesthetics for human use; inhalant anesthetic; pharmaceutical preparations for the induction of local anesthesia; general anesthetics for human use; transdermal patches featuring scopolamine for treatment of nausea and vomiting; antibiotics for human use; sedatives for human use; injectable pharmaceuticals for treatment of infections, bacterial infections, viral infections, pain, fever, hypertension, low blood pressure, heart, chest pain, hemodynamic imbalances, blood clots, ulcers, ventricular fibrillation, yeast infections, fungal infections, heart failure, diabetes, cancer, nausea and vomiting, edema, constipation, cirrhosis, opioid overdose, poisoning, heavy bleeding, dehydration, swelling, low magnesium, acne, rapid heartbeats, and low calcium; prescription medicines, namely, pills, tablets, capsules and pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of nausea, vomiting, and damage to bladder; pharmaceutical preparations to temporarily arrest the heart; injectable cardiac support for cardiac support; potassium preparations for pharmaceutical purposes; insulin; pharmaceutical preparations, namely, irrigation solutions for flushing, rinsing and cleansing of body tissues, body cavities, and wounds; medical instruments, namely, medical containers and medical bags sold filled with medical liquids and solutions, namely irrigation solutions; amino acid preparations for medical purposes; liquid nutritional supplement; liquid vitamin supplements; saline solution for medical purposes; sterile water for medical purposes.